The FDA just approved its weight loss drug called a game changer - BGR

0 42

The obesity rate in the United States is increasing at an absolutely incredible rate. It is estimated that about 40% of all adults in the United States are obese and an additional 30% are at least overweight. The statistics are troubling, especially with the number of illnesses linked to high body weight. Being overweight or obese dramatically increases your chances of developing type 2 diabetes, high blood pressure, sleep disturbances, heart disease, and even some cancers.

Unfortunately, many societal factors have hampered efforts to promote fitness. We are surrounded by countless meal options, and some of the unhealthy ones are often also the easiest to obtain and the cheapest. The work-work-work habit of many Americans often leaves little room for an exercise routine, especially when the majority of adults report feeling chronically stressed. It is a combination of factors that makes it incredibly easy to gain weight and harder to lose. Now the United States Food and Drug Administration approved a new drug for the treatment of obesity, but this is actually nothing new at all.

Best deal of the day Prime Day 2021 early eruption: Prime members can get Blink Mini cameras for just $ 19,99 right now! List of prices:$ 34,99 Price:$ 19,99 You save:$ 15,00 (43%) Available on Amazon, BGR may receive a commission Buy now Available on Amazon BGR may receive commission

The drug is called Wegovy, and it has already been approved for the treatment of type 2 diabetes. The Wegovy compound that does the heavy lifting is called semaglutide, and it is an analogue of a natural hormone that can affect the feeling of hunger. Its properties make it an option for people with diabetes (if they can handle the side effects), and as more patients have been treated with the drug, doctors have reported dramatic weight loss as a side effect. positive.

As is often the case when a company realizes that one of its drugs can be useful for the treatment of several diseases, the pharmaceutical giant Novo Nordisk has decided to seek approval for semaglutide in the treatment of obesity as well. . The FDA has now given the drug the green light. In trials, the drug - in combination with diet and exercise - helped patients lose more than 12% more weight than those who took a placebo with the same lifestyle changes. .

As promising as this drug may sound, it is not without its risks. Side effects can include diarrhea, vomiting, headache, and abdominal pain. In animal trials of the drug, thyroid tumors have appeared in some cases, although these same tumors have not appeared in human trials. Nonetheless, the drug will carry a warning on the box that it may increase the chances of developing thyroid tumors.

Ultimately, aside from the rare medical conditions that actually prevent the body from losing weight regardless of diet and exercise, the best solution to obesity is a diet low in processed foods and sugars, and high in sugar. plants and high-quality protein, as well as plenty of physical activity. It is often difficult to change your lifestyle to focus on these factors, but it should always be your first step if you are determined to lose weight. Can an obesity drug help? Yes, it is possible, but it is no coincidence that in drug trials it was prescribed with a change in diet and exercise.

Best deal of the day Prime Day 2021 early eruption: Prime members can get Blink Mini cameras for just $ 19,99 right now! List of prices:$ 34,99 Price:$ 19,99 You save:$ 15,00 (43%) Available on Amazon, BGR may receive a commission Buy now Available on Amazon BGR may receive commission

This article first appeared on https://bgr.com/science/obesity-drug-fda-approved-5929931/

Leave a comment